Occudo Quantitative Strategies’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Occudo Quantitative Strategies’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-17,270	Closed	-$320K	–	1293
2023 Q3	$320K	Buy	+17,270	New	+$195K	0.04%	646
2022 Q4	–	Sell	-63,700	Closed	-$889K	–	1481
2022 Q3	$889K	Buy	63,700 +46,720	+275%	+$752K	0.07%	453
2022 Q2	$234K	Sell	16,980 -18,011	-51%	-$288K	0.02%	864
2022 Q1	$569K	Buy	+34,991	New	+$548K	0.05%	591
2021 Q1	–	Sell	-32,572	Closed	-$805K	–	970
2020 Q4	$805K	Buy	+32,572	New	+$1.08M	0.25%	102

Occudo Quantitative Strategies's ICPT Position: Q4 2023 in Review

Occudo Quantitative Strategies sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 17,270 shares — an estimated $320K sold.

Occudo Quantitative Strategies first reported a position in ICPT in Q4 2020 and held it in 5 quarters. The position peaked at $889K in Q3 2022. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Occudo Quantitative Strategies reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Occudo Quantitative Strategies sold 17,270 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $320K.
Occudo Quantitative Strategies first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2020 and held it in 5 quarters.
Occudo Quantitative Strategies's Intercept Pharmaceuticals, Inc. position peaked at $889K in Q3 2022.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.